Information Services Group, Inc. (III) Latest News

NASDAQ Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$3.35

north_east $0.02 (0.6%)

Day's range

$3.33

$3.37

Latest News of III

Kenneth Walker III ruled out for Seahawks heading into crucial NFC West game vs. Cardinals

Kenneth Walker III ruled out for Seahawks heading into crucial NFC West game vs. Cardinals

By AP NEWS | 2 weeks ago

Shumate's 22 help McNeese beat Div. III-LeTourneau 103-69

Shumate's 22 help McNeese beat Div. III-LeTourneau 103-69

By AP NEWS | 2 weeks ago

Akron routs Division III-SUNY-Brockport 101-48

Akron routs Division III-SUNY-Brockport 101-48

By AP NEWS | 2 weeks ago

Seahawks Provide Massive Injury Update on Kenneth Walker III

Seahawks Provide Massive Injury Update on Kenneth Walker III

By Newsweek | 2 weeks ago

Deion Sanders, ex-wife were apart at senior day celebration for sons Shedeur and Shilo: 'Like WWIII'

Deion Sanders, ex-wife were apart at senior day celebration for sons Shedeur and Shilo: 'Like WWIII'

By Fox News | 3 weeks ago

World War III Is Heating Up On Several Fronts, But Most Americans Have No Idea...

World War III Is Heating Up On Several Fronts, But Most Americans Have No Idea...

By The Washington Standard | 3 weeks ago

Europe quietly prepares for World War III

Europe quietly prepares for World War III

By Newsweek | 3 weeks ago

Missouri WR Luther Burden III declares for the NFL draft

Missouri WR Luther Burden III declares for the NFL draft

By AP NEWS | 3 weeks ago

Missouri WR Luther Burden III, potential top-15 pick, declares for 2025 NFL Draft

Missouri WR Luther Burden III, potential top-15 pick, declares for 2025 NFL Draft

By The New York Times | 3 weeks ago

Four oral GLP-1R products in Phase III trials as race intensifies

Four oral GLP-1R products in Phase III trials as race intensifies

By Yahoo! Finance | 3 weeks ago

Novocure seeks approval after pancreatic cancer wearable scores at Phase III

Novocure seeks approval after pancreatic cancer wearable scores at Phase III

By Yahoo! Finance | 3 weeks ago

Dynes scores 23, Youngstown State routs Div. III-Bethany (WV) 128-60

Dynes scores 23, Youngstown State routs Div. III-Bethany (WV) 128-60

By AP NEWS | 3 weeks ago

Telix Pharma doses first patient in Phase III PET carcinoma trial

Telix Pharma doses first patient in Phase III PET carcinoma trial

By Yahoo! Finance | 3 weeks ago

Outlook Therapeutics stock craters as the wet AMD drug fails Phase III trial

Outlook Therapeutics stock craters as the wet AMD drug fails Phase III trial

By Yahoo! Finance | 4 weeks ago

Outlook Therapeutics stock craters as wet AMD drug fails Phase III trial

Outlook Therapeutics stock craters as wet AMD drug fails Phase III trial

By Yahoo! Finance | 4 weeks ago